Innate immune tissue injury and murine HGA - Tissue injury in the murine model of granulocytic anaplasmosis relates to host innate immune response and not pathogen load

被引:12
作者
Scorpio, Diana G.
Von Loewenich, Friederike D.
Bogdan, Christian
Dumler, J. Stephen
机构
[1] Johns Hopkins Univ, Sch Med, Dept Comparat Med, Baltimore, MD 21205 USA
[2] Univ Freiburg, Inst Med Microbiol & Hyg, Freiburg, Germany
[3] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA
来源
RICKETTSIOSES: FROM GENOME TO PROTEOME, PATHOBIOLOGY, AND RICKETTSIAE AS AN INTERNATIONAL THREAT | 2005年 / 1063卷
关键词
Anaplasma phagocytophilum; TNF; NOS2; phagocyte oxidase; innate immunity; mouse model;
D O I
10.1196/annals.1355.077
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Anaplasma phagocytophilum is an obligate intracellular tick-borne bacterium that propagates within neutrophils and causes human and animal granulocytic anaplasmosis (HGA). In the murine model of HGA, host immune response plays a more important role in histopathologic lesions than does pathogen load. We examined the role of CYBB, NOS2, and TNF alpha as effectors of innate immune-related injury. Our hypothesis is that the innate immune response to A. phagocytophilum results in inflammatory histopathology, but does not control the pathogen.
引用
收藏
页码:425 / 428
页数:4
相关论文
共 6 条
[1]   Exploitation of interleukin-8-induced neutrophil chemotaxis by the agent of human granulocytic ehrlichiosis [J].
Akkoyunlu, M ;
Malawista, SE ;
Anguita, J ;
Fikrig, E .
INFECTION AND IMMUNITY, 2001, 69 (09) :5577-5588
[2]   Anaplasma phagocytophilum utilizes multiple host evasion mechanisms to thwart NADPH oxidase-mediated killing during neutrophil infection [J].
Carlyon, JA ;
Latif, DA ;
Pypaert, M ;
Lacy, P ;
Fikrig, E .
INFECTION AND IMMUNITY, 2004, 72 (08) :4772-4783
[3]  
Martin A, 2001, WOMEN HIST REV, V10, P158
[4]   CXCR2 blockade influences Anaplasma phagocytophilum propagation but not histopathology in the mouse model of human granulocytic anaplasmosis [J].
Scorpio, DG ;
Akkoyunlu, M ;
Fikrig, E ;
Dumler, JS .
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 2004, 11 (05) :963-968
[5]  
Segal BH, 2002, J LEUKOCYTE BIOL, V71, P410
[6]  
von Loewenich FD, 2004, EUR J IMMUNOL, V34, P1789, DOI 10.1002/eji.200425250